Targeting of the Human Coagulation Factor IX Gene at rDNA Locus of Human Embryonic Stem Cells

by Xionghao Liu, Yong Wu, Zhuo Li, Junlin Yang, Jinfeng Xue, Youjin Hu, Mai Feng, Wenbin Niu, Qiurui Yang, Ming Lei, Jiahui Xia, Lingqian Wu, Desheng Liang

Background

Genetic modification is a prerequisite to realizing the full potential of human embryonic stem cells (hESCs) in human genetic research and regenerative medicine. Unfortunately, the random integration methods that have been the primary techniques used keep creating problems, and the primary alternative method, gene targeting, has been effective in manipulating mouse embryonic stem cells (mESCs) but poorly in hESCs.

Methodology/Principal Findings

Human ribosomal DNA (rDNA) repeats are clustered on the short arm of acrocentric chromosomes. They consist of approximately 400 copies of the 45S pre-RNA (rRNA) gene per haploid. In the present study, we targeted a physiological gene, human coagulation factor IX, into the rDNA locus of hESCs via homologous recombination. The relative gene targeting efficiency (>50%) and homologous recombination frequency (>10⁻⁵) were more than 10-fold higher than those of loci targeted in previous reports. Meanwhile, the targeted clones retained both a normal karyotype and the main characteristics of ES cells. The transgene was found to be stably and ectopically expressed in targeted hESCs.

Conclusion/Significance

This is the first targeting of a human physiological gene at a defined locus on the hESC genome. Our findings indicate that the rDNA locus may serve as an ideal harbor for transgenes in hESCs.

For the full article visit: Targeting of the Human Coagulation Factor IX Gene at rDNA Locus of Human Embryonic Stem Cells
Syndicated from:PLoS ONE

Article is licensed under a Creative Commons Attribution License.